“... due to a delay experienced by the Registrant in preparing disclosure relating to recent developments regarding clinical trials for the Registrant’s lead drug compound, and in particular, developments on or around the filing due date relating to clinical trials in the United States and Russia.[\b]The Registrant anticipates that it will file the Quarterly Report no later than the fifth calendar day following the prescribed filing due date.”
News 
Market Data 
Discover 
AI
